Synchrony Medical

Airway Clearance System for Home Use

Health Tech & Life Sciences
Active
Seed Or Yehuda Founded 2020
Total raised
$6.8M
Last: Undisclosed 2026-02
Stage
Seed
Founded
2020
Headcount
10
HQ
Or Yehuda
Sector
Health Tech & Life Sciences

About

Synchrony Medical is a clinical-stage medical device company and the developer of LibAirty, a next-generation airway clearance system for home use. LibAirty is designed to help patients with chronic lung diseases, such as chronic obstructive pulmonary disease and cystic fibrosis, maintain clear lungs with a short and effective daily treatment.

Funding history · 3 rounds · $6.8M total

2026-02
Undisclosed $5.0M
2025-09
Undisclosed $1.0M
2020-10
Seed $800K

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

When was Synchrony Medical founded and what is its primary focus?
Synchrony Medical was founded in October 2020. It is a clinical-stage medical device company developing LibAirty, a next-generation airway clearance system for home use, targeting patients with chronic lung diseases.
What is the total amount of funding Synchrony Medical has raised to date?
Synchrony Medical has raised a total of $6.8 million in funding.
Which investor led Synchrony Medical's initial Seed round?
MEDX Xelerator led Synchrony Medical's Seed round in October 2020.
When did Synchrony Medical secure its most recent funding round and who was the lead investor?
Synchrony Medical secured its most recent funding round in February 2026, raising $5 million. Edge Medical Ventures was the lead investor.
What significant regulatory milestone did Synchrony Medical achieve in July 2025?
In July 2025, Synchrony Medical received FDA approval for its LibAirty airway clearance technology.
When did Synchrony Medical launch its LibAirty Airway Clearance System in the US market?
Synchrony Medical launched its LibAirty Airway Clearance System in the US in October 2025.
In which month and year did Synchrony Medical begin enrolling patients for a US study of its LibAirty system?
Synchrony Medical began enrolling its first patients in a US study for regulatory submission of its LibAirty Airway Clearance System in February 2023.
Which medical institution initiated a clinical trial with Synchrony Medical for a personalized chest physiotherapy system?
Sheba Medical Center and Synchrony Medical initiated a first clinical trial in April 2021, using a personalized chest physiotherapy system for patients with chronic lung diseases.
What was a key finding from a clinical study on Synchrony Medical's LibAirty system conducted at the Medical University of South Carolina?
A clinical study conducted at the Medical University of South Carolina in October 2023 found Synchrony Medical's LibAirty Airway Clearance System to be highly effective for chronic lung disease patients.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & TherapeuticsDigital HealthcarePatient Remote Monitoring
Technologies
Platforms & InterfacesMobileSensing
Target customers
Healthcare & Life SciencesHealthcarePatientsProviders
Business model
B2B

Highlights

Verified

Tags

chronic-patientsremote-monitoringdigital-healthcaretreatmentsmedical-devicesrespiratorysensorspulmonarypatientstherapeuticsphysiotherapypersonalizationhome-carehealthcare-providers